Zheshang Securities(SH:601878) Xin Lang Cai Jing·2025-09-12 06:30Group 1 - The core viewpoint of the news is that Shutaishen (Beijing) Biopharmaceutical Co., Ltd. has seen a stock price increase of 5.06%, reaching 41.71 CNY per share, with a trading volume of 1.532 billion CNY and a turnover rate of 8.45%, resulting in a total market capitalization of 19.928 billion CNY [1] - Shutaishen was established on August 16, 2002, and went public on April 15, 2011. The company primarily engages in the research, production, and sales of biological products and some chemical drugs [1] - The main revenue composition of Shutaishen includes 59.17% from injectable mouse nerve growth factor (Sutai), 33.19% from compound polyethylene glycol electrolyte powder, and 7.63% from other products [1] Group 2 - According to data from the top ten heavy stocks of funds, one fund under Zheshang Securities Asset Management holds a significant position in Shutaishen. The Zheshang Huijin Quantitative Selected Mixed Fund (006449) held 143,900 shares in the second quarter, accounting for 5.18% of the fund's net value, making it the second-largest heavy stock [2] - The Zheshang Huijin Quantitative Selected Mixed Fund (006449) was established on March 25, 2019, with a latest scale of 104 million CNY. It has achieved a return of 66.21% this year, ranking 340 out of 8,174 in its category, and a return of 96.2% over the past year, ranking 530 out of 7,981 [2]